Evidence map›Paper›PMID 40464171›Full record

ArticleCurrent medical imaging2025

CT Quantitative Analysis in Evaluating Type 2 Diabetes Mellitus Complicated with Interstitial Lung Abnormalities

Li Zhang, Qiu-Ju Fan, Shan Dang, Dong Han, Min Zhang, Shu-Guang Yan, Xiao-Kun Xin, Nan Yu

Abstract read
In one paragraph

Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Li ZhangSchool of Medical Technology, Shaanxi University of Chinese Medicine, Xianyang, China.
Qiu-Ju FanDepartment of Medical Imaging, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China.
Shan DangDepartment of Medical Imaging, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China.
Dong HanDepartment of Medical Imaging, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China.
Min ZhangDepartment of Medical Imaging, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China.
Shu-Guang YanSchool of Medical Technology, Shaanxi University of Chinese Medicine, Xianyang, China.
Xiao-Kun XinSchool of Medical Technology, Shaanxi University of Chinese Medicine, Xianyang, China.
Nan YuSchool of Medical Technology, Shaanxi University of Chinese Medicine, Xianyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes mellitus (T2DM) complicated with interstitial lung abnormalities (ILAs) is often overlooked and can progress to severe diabetesinduced pulmonary fibrosis (DiPF). Therefore, early diagnosis of T2DM complicated with ILAs is crucial. Chest computed tomography (CT) is an important method for diagnosing T2DM complicated with ILAs. Quantitative computed tomography (QCT) is more objective and accurate than visual assessment on CT. However, there are currently limited studies on T2DM complicated with ILAs based on quantitative CT.

objectiveThis study aimed to explore the utility of quantitative computed tomography for early detection of lung injury in individuals with T2DM by examining CT-derived metrics in T2DM complicated with ILAs.

methodsWe collected data from 135 T2DM complicated with ILAs on chest CT scans retrospectively, alongside 135 non-diabetic controls with normal CT findings. Employing digital lung software, chest CT images were processed to extract quantitative parameters: total lung volume (TLV), emphysema index (LAA-950%, the percentage of lung area with attenuation < –950 Hu to total lung volume), pulmonary fibrosis index (LAA-700~-200%, the percentage of lung area with attenuation from –700Hu to –200 Hu to the total lung volume), and pulmonary peripheral vascular index (ratio TAV/TNV, the number of blood vessels TNV, the cross-sectional area of blood vessels TAV). Statistical comparisons between groups utilized Mann-Whitney U or t-tests. Correlations between Hemoglobin A1c (HbA1c) levels and CT parameters were assessed via Pearson or Spearman correlations. Parameters showing statistical significance were further examined through receiver operating characteristic (ROC) analysis.

resultsThe T2DM-ILAs cohort displayed a significantly higher LAA-700~-200% compared to controls (Z = -7.639, P< 0.001), indicative of increased fibrotic changes. Conversely, TLV (Z =-3.120, P=0.002), TAV/TNV (Z = -9.564, P< 0.001), and LAA-950% (Z = -4.926, P < 0.001) were reduced in T2DM-ILAs patients. The correlation between HbA1c and various CT quantitative indicators was not significant, HbA1c and TLV (r=-0.043, P=0.618), HbA1c and TAV (r=0.143, P=0.099), HbA1c and TNV (r=0.064, P=0.461), HbA1c and LAA-700~-200% (r=0.102, P=0.239), HbA1c and LAA-950% (r=-0.170, P=0.049), HbA1c and TAV/TNV (r=0.175, P=0.043). The peripheral vascular marker, TAV/TNV, excelled in distinguishing T2DM-related lung changes (AUC=0.84, P<0.001), outperforming LAA-700~-200% (AUC=0.77,P<0.001). A composite index incorporating multiple quantitative parameters achieved the highest diagnostic accuracy (AUC = 0.91, P< 0.001).

conclusionQuantitative CT parameters distinguish T2DM complicated with ILAs from non-diabetic individuals, suggesting a distinct pattern of lung injury. Our findings imply a particular susceptibility of small pulmonary blood vessels to injury in T2DM.

Indexed as

Diabetes Mellitus, Type 2Lung Diseases, InterstitialTomography, X-Ray ComputedAdultAgedFemaleHumansLungMaleMiddle AgedRetrospective Studies, Computed tomographyHemoglobin A1c, Interstitial lung abnormalitiesLung damageQuantitative analysisType 2 diabetes mellitus

Identifiers

PMID40464171
PMCPMC13181192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.